Well said Mikeyt. I would add to your estimates b

Well said Mikeyt. I would add to your estimates by simply making a comparison. Tilray has a market cap of about 10 billion dollars. Yet, they primarily operate in Canada which has only a fraction of the market the United States has and far smaller distribution. AGRiMED seems poised to become the American version of Tilray, and that is only one company in this group of companies. Currently, Univec appears to be the primary beneficiary of the partnerships and joint ventures that are forming, and Univec has a mind-boggling 70,000 pharmacy distribution network. You do the math. If a single patch retails for lets say $40.00, and we have a dozen or so patches treating everything from sleep disorders to cancer, what do you think the market cap could be? I dare say you will not find any other company with the reach and potential that Univec alone could have. But, Univec is only one company is this group of at least four, and the partnerships and joint ventures multiply that number even more.